Literature DB >> 14594693

Extracorporeal magnetic stimulation for the treatment of stress and urge incontinence in women--results of 1-year follow-up.

Ali Unsal1, Remzi Saglam, Ersin Cimentepe.   

Abstract

OBJECTIVE: To evaluate the clinical efficacy of extracorporeal magnetic stimulation for the treatment of stress and urge urinary incontinence in women.
MATERIAL AND METHODS: A total of 35 patients with stress incontinence and 17 with urge incontinence were enrolled in this study. All patients were evaluated by means of a detailed history of incontinence, a gynecologic examination, urine culture, urinary system ultrasound and a urodynamic study. All patients were asked to keep a 3-day voiding diary. A pad-weighing test was done for each patient at their first visit. For treatment, the patients were seated on a special chair containing a magnetic field generator. Pelvic floor muscle stimulation was performed for 20 min (10 min at 5 Hz and 10 min at 50 Hz) twice a week for a total of 8 weeks. The mean follow-up period was 16.8 months (range 12-32 months). A total of 44 patients completed 1 year of follow-up and were re-evaluated by means of voiding diary, pad-weighing test and cystometric study.
RESULTS: Of the 44 patients, 11 (38%) with stress incontinence and 6 (40%) with urge incontinence were cured 1 year after the treatment. In addition, there was an improvement in symptoms in 12 patients (41%) in the stress group and 7 (47%) in the urge group. Pad weight was reduced from 15.4 to 5.8 g in the stress group and from 12.4 to 4.7 g in the urge group (p = 0.000 and 0.001, respectively). Mean Valsalva leak point pressure was increased from 87.3 +/- 15.9 to 118.0 +/- 11.0 cmH (2) O in the stress group (p = 0.000).
CONCLUSIONS: Extracorporeal magnetic stimulation therapy offers a non-invasive, effective and painless treatment for stress and urge incontinence in women.

Entities:  

Mesh:

Year:  2003        PMID: 14594693     DOI: 10.1080/00365590310021258

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  7 in total

1.  Patients' perception and satisfaction with pulsed magnetic stimulation for treatment of female stress urinary incontinence.

Authors:  Renly Lim; Men Long Liong; Wing Seng Leong; Nurzalina Abdul Karim Khan; Kah Hay Yuen
Journal:  Int Urogynecol J       Date:  2017-07-25       Impact factor: 2.894

2.  Symptom change in women with overactive bladder after extracorporeal magnetic stimulation: a prospective trial.

Authors:  Jin Ho Choe; Myung-Soo Choo; Kyu-Sung Lee
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-30

3.  A prospective randomised double-blind controlled trial evaluating the effect of trans-sacral magnetic stimulation in women with overactive bladder.

Authors:  B A O'Reilly; M Fynes; C Achtari; R Hiscock; E Thomas; C Murray; P L Dwyer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-12

4.  Magnetic stimulation for stress urinary incontinence: study protocol for a randomized controlled trial.

Authors:  Renly Lim; Men Long Liong; Wing Seng Leong; Nurzalina Abdul Karim Khan; Kah Hay Yuen
Journal:  Trials       Date:  2015-06-21       Impact factor: 2.279

Review 5.  Urinary Incontinence in Women: Modern Methods of Physiotherapy as a Support for Surgical Treatment or Independent Therapy.

Authors:  Agnieszka Irena Mazur-Bialy; Daria Kołomańska-Bogucka; Caroline Nowakowski; Sabina Tim
Journal:  J Clin Med       Date:  2020-04-23       Impact factor: 4.241

6.  Magnetic stimulation for female patients with stress urinary incontinence, a meta-analysis of studies with short-term follow-up.

Authors:  Liao Peng; Xiao Zeng; Hong Shen; De-Yi Luo
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Assessment of the Short-Term Effects after High-Inductive Electromagnetic Stimulation of Pelvic Floor Muscles: A Randomized, Sham-Controlled Study.

Authors:  Kuba Ptaszkowski; Bartosz Malkiewicz; Romuald Zdrojowy; Lucyna Ptaszkowska; Malgorzata Paprocka-Borowicz
Journal:  J Clin Med       Date:  2020-03-23       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.